3 results
Approved WMORecruiting
To attenuate the impact and duration of delayed graft funtion by dampening schemia reperfusion injury
Approved WMOCompleted
To study the potential renoprotective effects of supplementation of alkaline phosphatase in hospitalized patients with AKI
Approved WMORecruiting
Primary Part 1:-To evaluate ORR in participants treated with MK-4280A plus EV (Arm A), MK-7684A plus EV (Arm B), and pembrolizumab plus EV(Arm C) per RECIST 1.1 by BICR.- To evaluate the safety and tolerability in participants treated with MK-4280A…